30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Medpace Research Inc (NRX)

Stock chart
Ticker: NRX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Rho Ventures V, L.P.
1 sale — total 207,339 USD
Sale 6 Jan 2015
Value US$2,200,064.05 | Price 73.74 | Shares 52,588
Sale 5 Jan 2015
Value US$2,355,130.50 | Price 250.47 | Shares 33,903
Sale 2 Jan 2015
Value US$953,207.20 | Price 10.83 | Shares 88,000
Buy 25 Nov 2014
Value US$8,400.00 | Price 4.20 | Shares 2,000
Buy 14 Feb 2014
Value US$9,480,000.00 | Price 12.00 | Shares 790,000
Buy 14 Feb 2014
Value US$9,480,000.00 | Price 12.00 | Shares 790,000
Buy 14 Feb 2014
Value US$9,480,000.00 | Price 12.00 | Shares 790,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2015-01-06 2015-01-06 S Sale Rho Ventures V, L.P. Large shareholder
52,588 +35.8%
73.74
US$2,200,064
52,588 +35.8% 73.74 US$2,200,064
2015-01-06 2015-01-05 S Sale Rho Ventures V, L.P. Large shareholder
33,903 +11.9%
250.47
US$2,355,131
33,903 +11.9% 250.47 US$2,355,131
2015-01-06 2015-01-02 S Sale Rho Ventures V, L.P. Large shareholder
79,236 -31.6%
186.41
US$3,012,843
79,236 -31.6% 186.41 US$3,012,843
2014-11-25 2014-11-25 B Purchase Peterson Bob

VP of Prod. Dev. & Reg. Aff's.

Officer
2,000 +inf%
4.20
US$8,400
2,000 +inf% 4.20 US$8,400
2014-02-19 2014-02-14 B Purchase Seltzer Robert R. Non-Executive Director Large shareholder
790,000 +22.9%
12.00
US$9,480,000
790,000 +22.9% 12.00 US$9,480,000
2014-02-19 2014-02-14 B Purchase Markham Richard J Non-Executive Director Large shareholder
790,000 +22.9%
12.00
US$9,480,000
790,000 +22.9% 12.00 US$9,480,000
2014-02-19 2014-02-14 B Purchase Care Capital III LLC Non-Executive Director Large shareholder
790,000 +22.9%
12.00
US$9,480,000
790,000 +22.9% 12.00 US$9,480,000
Explore more

More insider trading research around Medpace Research Inc